How many insider trades does FilingIQ track for NEO?

FilingIQ tracks 659 Form 4 insider transactions for NEO (NEOGENOMICS INC), covering filings from Apr 16, 2015 onwards. 49 of those were filed in the last 90 days.

Are NEO insiders net buyers or net sellers?

Across the full Form 4 history for NEO, 15 transactions (2%) were open-market purchases and 149 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NEO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NEO in?

NEOGENOMICS INC (NEO) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $1.29B.

NEO insider trading

NasdaqCM Healthcare

NEOGENOMICS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

659

Last 90 days

Buys / sells

2% / 23%

Market cap

$1.29B

About NEOGENOMICS INC

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Company website: www.neogenomics.com

NEO insider activity at a glance

FilingIQ has scored 659 insider transactions for NEO since Apr 16, 2015. The most recent filing in our index is dated May 11, 2026.

Across the full history, 15 open-market purchases and 149 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NEO insider trades is 59.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NEO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NEO?: FilingIQ tracks 659 Form 4 insider transactions for NEO (NEOGENOMICS INC), covering filings from Apr 16, 2015 onwards. 49 of those were filed in the last 90 days.
Are NEO insiders net buyers or net sellers?: Across the full Form 4 history for NEO, 15 transactions (2%) were open-market purchases and 149 (23%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NEO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NEO in?: NEOGENOMICS INC (NEO) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $1.29B.

Methodology & sources

Every NEO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.